Literature DB >> 17922052

Complex organizational defects of fibroblast architecture in the mouse spleen with Nkx2.3 homeodomain deficiency.

Judit Bovári1, Tamás Czömpöly, Katinka Olasz, Hans-Henning Arnold, Péter Balogh.   

Abstract

The capacity of secondary lymphoid organs to provide suitable tissue environment for mounting immune responses is dependent on their compartmentalized stromal constituents, including distinct fibroblasts. In addition to various members of the tumor necrosis factor/lymphotoxin beta family as important morphogenic regulators of peripheral lymphoid tissue development, the formation of stromal elements of spleen is also influenced by the Nkx2.3 homeodomain transcription factor in a tissue-specific fashion. Here we extend our previous work on the role of Nkx2.3-mediated regulation in the development of spleen architecture by analyzing the structure of reticular fibroblastic meshwork of spleen in inbred Nkx2.3-deficient mice. Using immunohistochemistry and dual-label immunofluorescence we found both distributional abnormalities, manifested as poor reticular compartmentalization of T-zone and circumferential reticulum, and developmental blockade, resulting in the absence of a complementary fibroblast subpopulation of white pulp. The disregulated distribution of fibroblasts was accompanied with an increased binding of immunohistochemically detectable complement factor C4 by T-cell zone-associated reticular fibroblasts, distinct from follicular dendritic cells with inherently high-level expression of bound C4. These data indicate that the impact of Nkx2.3 gene deficiency on fibroblast ontogeny within the spleen extends beyond its distributional effects, and that the formation of various white pulp fibroblast subsets is differentially affected by the presence of Nkx2.3 activity, possibly also influencing their role in various immune functions linked with complement activation and deposition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922052     DOI: 10.1007/bf02893503

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  Selective malformation of the splenic white pulp border in L1-deficient mice.

Authors:  S L Wang; M Kutsche; G DiSciullo; M Schachner; S A Bogen
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

Review 2.  Organogenesis of lymphoid tissues.

Authors:  Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  Antigenic heterogeneity of the reticular meshwork in the white pulp of mouse spleen.

Authors:  K Yoshida; N Tamahashi; N Matsuura; T Takahashi; T Tachibana
Journal:  Cell Tissue Res       Date:  1991-11       Impact factor: 5.249

4.  Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen.

Authors:  G Kraal; K Schornagel; P R Streeter; B Holzmann; E C Butcher
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

5.  Enhancement of terminal B lymphocyte differentiation in vitro by fibroblast-like stromal cells from human spleen.

Authors:  G Skibinski; A Skibinska; G D Stewart; K James
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

6.  Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody.

Authors:  E Van Vliet; M Melis; J M Foidart; W Van Ewijk
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

7.  Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.

Authors:  Jeffrey L Browning; Lars E French
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

8.  Homeodomain factor Nkx2-3 controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera.

Authors:  C C Wang; C Biben; L Robb; F Nassir; L Barnett; N O Davidson; F Koentgen; D Tarlinton; R P Harvey
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

9.  Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen.

Authors:  P Balogh; Y Aydar; J G Tew; A K Szakal
Journal:  Cell Immunol       Date:  2001-11-25       Impact factor: 4.868

Review 10.  Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting.

Authors:  Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Stanislav A Rybtsov; Ekaterina P Koroleva; Junji Takeda; Sergei A Nedospasov; Dmitry V Kuprash
Journal:  Immunol Rev       Date:  2003-10       Impact factor: 12.988

View more
  3 in total

1.  Absence of Nkx2-3 homeodomain transcription factor induces the formation of LYVE-1-positive endothelial cysts without lymphatic commitment in the spleen.

Authors:  Zoltán Kellermayer; Arpád Lábadi; Tamás Czömpöly; Hans-Henning Arnold; Péter Balogh
Journal:  J Histochem Cytochem       Date:  2011-07       Impact factor: 2.479

Review 2.  Recent advances in the genetics of autoimmune disease.

Authors:  Peter K Gregersen; Lina M Olsson
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.

Authors:  Eloy F Robles; Maria Mena-Varas; Laura Barrio; Sara V Merino-Cortes; Péter Balogh; Ming-Qing Du; Takashi Akasaka; Anton Parker; Sergio Roa; Carlos Panizo; Idoia Martin-Guerrero; Reiner Siebert; Victor Segura; Xabier Agirre; Laura Macri-Pellizeri; Beatriz Aldaz; Amaia Vilas-Zornoza; Shaowei Zhang; Sarah Moody; Maria Jose Calasanz; Thomas Tousseyn; Cyril Broccardo; Pierre Brousset; Elena Campos-Sanchez; Cesar Cobaleda; Isidro Sanchez-Garcia; Jose Luis Fernandez-Luna; Ricardo Garcia-Muñoz; Esther Pena; Beatriz Bellosillo; Antonio Salar; Maria Joao Baptista; Jesús Maria Hernandez-Rivas; Marcos Gonzalez; Maria Jose Terol; Joan Climent; Antonio Ferrandez; Xavier Sagaert; Ari M Melnick; Felipe Prosper; David G Oscier; Yolanda R Carrasco; Martin J S Dyer; Jose A Martinez-Climent
Journal:  Nat Commun       Date:  2016-06-14       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.